FDA Adverse Event Injury Summary report: N

ULTRACISION HARMONIC ACE (EXACT CODE UNKNOWN)

MDR report key: 9376470 · Received November 26, 2019

Report

Report Number
3005075853-2019-23781
Event Type
Injury
Date Received
November 26, 2019
Date of Event
January 1, 2013
Report Date
October 30, 2019
Manufacturer
ETHICON ENDO-SURGERY, LLC.
Product Code
LFL
PMA / PMN Number
K051036
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

LOT NUMBER IS UNKNOWN. THEREFORE, THE 510-K NUMBER IS UNKNOWN. COMPLAINANT PART IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. CONCOMITANT MEDICAL PRODUCTS: UNKNOWN. (B)(4). WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. PRODUCT WAS NOT RETURNED. BASED ON THE INFORMATION AVAILABLE, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND/OR PREVENTATIVE ACTION IS PROPOSED. THIS COMPLAINT WILL BE ACCOUNTED FOR AND MONITORED VIA POST MARKET SURVEILLANCE ACTIVITIES. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DATE SENT: 11/25/2019. DATE OF EVENT: PUBLICATION YEAR OF 2013. BATCH # UNK THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE MANUFACTURING RECORDS CANNOT BE REVIEWED AS THE LOT/BATCH NUMBER HAS NOT BEEN PROVIDED. (B)(4).

Description of Event or Problem · 1

TITLE : TOTAL LAPAROSCOPIC WERTHEIM¿S RADICAL HYSTERECTOMY VERSUS WERTHEIM¿S RADICAL ABDOMINAL HYSTERECTOMY IN THE MANAGEMENT OF STAGE I CERVICAL CANCER IN SINGAPORE: A PILOT STUDY. AUTHOR : YONG KUEI LIM1, MBBS, MRCOG, YIN NIN CHIA1, MBBS, MRCOG, KWAI LAM YAM1, MBBS, FRCOG. TITLE: TOTAL LAPAROSCOPIC WERTHEIM¿S RADICAL HYSTERECTOMY VERSUS WERTHEIM¿S RADICAL ABDOMINAL HYSTERECTOMY IN THE MANAGEMENT OF STAGE I CERVICAL CANCER IN SINGAPORE: A PILOT STUDY AUTHORS: YONG KUEI LIM, MBBS, MRCOG; YIN NIN CHIA, MBBS, MRCOG; KWAI LAM YAM, MBBS, FRCOG CITATION: SINGAPORE MED J 2013; 54(12): 683-688; DOI: 10.11622/SMEDJ.2013242. THE AIM OF THIS PROSPECTIVE STUDY WAS TO DESCRIBE THE EARLY EXPERIENCE OF TOTAL LAPAROSCOPIC WERTHEIM¿S RADICAL HYSTERECTOMY (TLRH) IN THE MANAGEMENT OF EARLY CERVICAL CANCER IN SINGAPORE. FROM NOVEMBER 2009 TO FEBRUARY 2011, A TOTAL OF 18 PATIENTS (MEAN AGE = 48 YEARS, AGE RANGE = 30-65 YEARS; MEAN BMI 22.9 KG/M^2, BMI RANGE = 16.0 ¿ 33.7 KG/M^2) UNDERWENT TO TLRH GROUP AND 30 PATIENTS (MEAN AGE = 47 YEARS, AGE RANGE = 33-67 YEARS; MEAN BMI 22.4 KG/M^2, BMI RANGE = 17.9 ¿ 33.9 KG/M^2) UNDERWENT WERTHEIM¿S RADICAL ABDOMINAL HYSTERECTOMY (RAH). TLRH BEGAN WITH THE DEVELOPMENT OF THE PELVIC SPACES. THE EXTERNAL ILIAC, INTERNAL ILIAC, OBTURATOR AND COMMON ILIAC LYMPH NODES WERE SYSTEMATICALLY REMOVED EN BLOC THROUGH THE SUPRAPUBIC PORT USING THE HARMONIC ACE CURVED SHEARS (ETHICON). THE URETERS WERE DISSECTED OFF THE MEDIAL PERITONEAL ATTACHMENTS BY BLUNT DISSECTION AND MOBILISED DOWN TO THE UTERINE ARTERIES. THE UTERINE ARTERY AND VEIN WERE TRANSECTED AT THE POINT OF ORIGIN FROM THE INTERNAL ILIAC VESSELS USING THE HARMONIC ACE CURVED SHEARS. REPORTED COMPLICATION IN TLRH GROUP INCLUDED MEDIAN BLOOD LOSS OF 300 ML (RANGE = 100 ¿ 1000 ML) (N=?); HAEMORRHAGE FROM THE PARAMETRIAL VESSELS (N=1) WHICH REQUIRED CONVERSION TO LAPAROTOMY. IN CONCLUSION, THE RESULTS OF THE STUDY SUGGEST THAT WITH APPROPRIATE PATIENT SELECTION AND INCREASED EXPERIENCE, TLRH CAN BE A SAFE AND EFFECTIVE PROCEDURE FOR THE MANAGEMENT OF EARLY CERVICAL CANCER IN (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1170985 ULTRACISION HARMONIC ACE (EXACT CODE UNKNOWN) INSTRUMENT, ULTRASONIC SURGICAL LFL ETHICON ENDO-SURGERY, LLC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention